ArticleAntonie van Leeuwenhoek2026
Computational design of oleuropein as a potential antifungal agent and enzyme engineering targeting multidrug-resistant fusarium species.
Article in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium species, including Fusarium oxysporum and Fusarium solani, pose significant threats to global agriculture due to their multidrug resistance (MDR), which reduces the efficacy of conventional fungicides. This study investigates the potential of Oleuropein, a natural phenolic compound, as a candidate antifungal agent targeting Fusarium-associated proteins. Molecular docking analysis indicated that oleuropein exhibits favorable binding affinity (- 6.6 kcal/mol) toward key fungal targets, supported by hydrogen bonding and hydrophobic interactions. The stability of the protein-ligand complex, evaluated using Normal Mode Analysis (NMA), suggests a stable interaction profile. Furthermore, in silico mutational analysis of the FoEG1 active site using Hotspot Wizard indicated enhanced binding interactions of oleuropein with selected variants compared to the native enzyme structure.Additionally, molecular dynamic results indicated the stability of ole and mutated enzyme interaction. In contrast to conventional azole-based fungicides, which primarily target ergosterol biosynthesis and are increasingly affected by resistance, oleuropein is predicted to interact with alternative protein targets, suggesting a potentially different mode of action. These findings highlight the utility of computational approaches in identifying natural compounds with antifungal potential and provide a foundation for future experimental validation.
Indexed as
Identifiers
42477213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.